Sippican Capital Advisors’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4K | Buy |
10,000
+4,667
| +88% | +$8.59K | 0.01% | 112 |
|
|
2025
Q1 | $14.2K | Buy |
5,333
+2,000
| +60% | +$5.34K | 0.01% | 109 |
|
|
2024
Q4 | $14.7K | Sell |
3,333
-1,234
| -27% | -$5.44K | 0.01% | 112 |
|
|
2024
Q3 | $71.9K | Sell |
4,567
-286
| -6% | -$4.5K | 0.05% | 113 |
|
|
2024
Q2 | $133K | Hold |
4,853
| – | – | 0.11% | 109 |
|
|
2024
Q1 | $175K | Buy |
4,853
+1,250
| +35% | +$45K | 0.14% | 109 |
|
|
2023
Q4 | $97K | Buy |
3,603
+1,730
| +92% | +$46.6K | 0.08% | 110 |
|
|
2023
Q3 | $61.3K | Buy |
1,873
+433
| +30% | +$14.2K | 0.06% | 103 |
|
|
2023
Q2 | $48.8K | Buy |
1,440
+540
| +60% | +$18.3K | 0.05% | 100 |
|
|
2023
Q1 | $45.9K | Buy |
+900
| New | +$45.9K | 0.04% | 99 |
|
|
2022
Q4 | – | Sell |
-125
| Closed | -$9K | – | 100 |
|
|
2022
Q3 | $9K | Buy |
+125
| New | +$9K | 0.01% | 99 |
|